These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11363652)

  • 1. HIV viral load supercedes CD4 count as best marker for predicting risk of AIDS and death.
    Baker R
    BETA; 1996 Jun; ():9-11. PubMed ID: 11363652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral load out-performs CD4 in disease prediction.
    AIDS Alert; 1996 Apr; 11(4):42-3. PubMed ID: 11363403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of HIV-1 viral load and CD4 lymphocyte count as determinants of progression to AIDS and survival].
    Romeu J; Balagué M; Ruiz L; Marfil S; Puig T; Arnó A; Veny A; Tural C; Sirera G; Clotet B
    Med Clin (Barc); 1998 Jun; 110(20):761-7. PubMed ID: 9666416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New era makes viral-load testing an important tool.
    AIDS Alert; 1996 Aug; 11(8):suppl 1-2. PubMed ID: 11363660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for diagnosis and treatment of HIV/AIDS in China (2005).
    ;
    Chin Med J (Engl); 2006 Oct; 119(19):1589-608. PubMed ID: 17042972
    [No Abstract]   [Full Text] [Related]  

  • 9. [HIV and AIDS: experiencing the symptoms. What cell count and viral burden do not tell us].
    Holzhemer WL
    Servir; 2003; 51(3):127-32. PubMed ID: 12889249
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD).
    Zhou J; Kumarasamy N;
    HIV Med; 2005 May; 6(3):216-23. PubMed ID: 15876289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPCRA to use viral load as marker for treatment. Community Programs for Clinical Research on AIDS.
    AIDS Alert; 1995 Aug; 10(8):105-7. PubMed ID: 11362678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata.
    Reekie J; Gatell JM; Yust I; Bakowska E; Rakhmanova A; Losso M; Krasnov M; Francioli P; Kowalska JD; Mocroft A;
    AIDS; 2011 Nov; 25(18):2259-68. PubMed ID: 21918422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people.
    Stebbing J; Sawleshwarkar S; Michailidis C; Jones R; Bower M; Mandalia S; Nelson M; Gazzard B
    Postgrad Med J; 2005 Sep; 81(959):586-8. PubMed ID: 16143689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The characteristics of opportunistic infections in 181 HIV/AIDS patients in China].
    Wang XC; Huang XJ; Zhang T; Liang LC; Jiao YM; Zhang HW; Wu H
    Zhonghua Nei Ke Za Zhi; 2007 May; 46(5):379-82. PubMed ID: 17637305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
    Gandhi T; Wei W; Amin K; Kazanjian P
    Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users.
    Tarwater PM; Gallant JE; Mellors JW; Gore ME; Phair JP; Detels R; Margolick JB; Muñoz A
    AIDS; 2004 Dec; 18(18):2419-23. PubMed ID: 15622318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of viral diversity in HIV pathogenesis.
    Goudsmit J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S15-9. PubMed ID: 8595502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical management of acute and chronic human immunodeficiency virus infection before starting antiretroviral treatment].
    Miró JM; Manzardo C; Zamora L; Pumarola T; Herreras Z; Gallart T; Gatell JM
    Enferm Infecc Microbiol Clin; 2011 Dec; 29(10):759-72. PubMed ID: 22078726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.